What they were paid
Forte Biosciences Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $52,067 | $0 | $200,539 | $0 | $252,606 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Forte Biosciences, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191515, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Forte Biosciences pays directors a $42,500 cash retainer.
Committees
FY2025 · as the proxy prints themAudit
The rest of the Forte Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barbara K. Finck, M.D | Director | $786,719 |
| Paul A. Wagner, Ph.D | Chair of the Board | $0 |
| Richard Vincent | Independent Director | $271,741 |
| Scott Brun, M.D | Independent Director | $255,019 |
| Shiv Kapoor | Independent Director | $248,039 |
| Stephen K. Doberstein, Ph.D | Independent Director | $250,019 |
| Steven Kornfeld | Independent Director | $288,153 |
The full Forte Biosciences compensation record
free company briefThis page is one director within Forte Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat